Jessica Cotrone | Vice President |
Simba Gill | Chief Executive Officer |
Mark Bodmer | President of R&D and Chief Scientific Officer |
Jonathan Zung | Chief Development Officer |
Roger Song | Jefferies |
Matthew Luchini | BMO Capital |
Matthew Harrison | Morgan Stanley |
Joe Thome | Cowen and Company |
Good morning, and welcome to Evelo Biosciences conference call to discuss the first-quarter 2021 financial results and business highlights. [Operator instructions] Please be advised that this call is being recorded at the company’s request. At this time, I’d like to turn the call over to Jessica Cotrone of Evelo. Please proceed.
Thank you.